Survival impact of concurrent chemoradiotherapy for elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma: A propensity score matching and landmark analyses

被引:11
|
作者
Shi, Zhenguo [1 ,2 ]
Zhu, Xiaojuan [2 ]
Ke, Shaobo [1 ]
Qiu, Hu [1 ]
Cai, Gaoke [1 ]
Zhangcai, Yutian [1 ]
Chen, Yongshun [1 ]
机构
[1] Wuhan Univ, Dept Clin Oncol, Renmin Hosp, Wuhan, Peoples R China
[2] Henan Univ Sci & Technol, Dept Oncol, Affiliated Hosp 1, Luoyang, Peoples R China
基金
中国国家自然科学基金;
关键词
Elderly patients; Synchronous oligometastatic esophageal; squamous cell carcinoma; Concurrent chemoradiotherapy; Survival; Nomogram; CLINICOPATHOLOGICAL CHARACTERISTICS; NEOADJUVANT CHEMORADIOTHERAPY; RADIATION-THERAPY; CANCER; RADIOTHERAPY; ONCOLOGY; CHEMOTHERAPY; MANAGEMENT; OUTCOMES; DISEASE;
D O I
10.1016/j.radonc.2021.09.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the potential benefits of concurrent chemoradiotherapy (CCRT), and to establish a nomogram for predicting survival outcomes of elderly patients with synchronous oligometastatic esophageal squamous cell carcinoma (SOEC). Materials and methods: This study eventually enrolled 314 elderly patients who initially diagnosed with SOEC from two centers. Treatment responses and outcomes of 151 patients receiving CCRT and 163 patients undergoing chemotherapy alone (CT) were compared. Propensity score matching and landmark analyses were performed to control potential confounding factors. A nomogram was established on the basis of the Cox regression model. Results: After a median follow-up of 42.3 months, CCRT was superior to CT alone in objective response rate (ORR, 59.6% vs. 39.9%, P < 0.001), median progression-free survival (PFS, 10.0 vs. 7.2 months, P < 0.001), and median overall survival (OS, 18.5 vs. 15.6 months, P < 0.001). The propensity score matching (PSM) and landmark analyses redemonstrated the same trend (P < 0.01). On hierarchical analysis, patients with 1- 3 metastatic lesions involving one organ displayed longer median PFS (9.0 vs. 7.8 months, P = 0.008) and OS (17.8 vs. 15.2 months, P < 0.001) than those with 4-5 metastatic lesions involving 2-3 organs. The major toxicities of grade III or higher for CCRT included leukocytopenia (23.2%), radiation esophagitis (7.3%), and radiation pneumonitis (8.6%). Cox multivariate analysis showed that the number of metastatic lesions (P = 0.012) and tumor response (P < 0.001) were independent prognostic factors associated with OS. A nomogram was established by incorporating the number of metastatic lesions and tumor response, with a concordance index of 0.743 after internal cross-validation. Calibration curves and decision curve analysis confirmed that nomogram had a favorable predictive value for individualized survival. Conclusions: Compared with CT alone, CCRT exhibited superior efficacy and acceptable toxicity in the first line treatment for elderly patients with SOEC. The current study supports the oligometastatic definition of <3 metastatic lesions involving one organ for esophageal cancer patients. The constructed nomogram can effectively predict the individualized survival. (c) 2021 Elsevier B.V. All rights reserved. Radiotherapy and Oncology 164 (2021) 236-244
引用
收藏
页码:236 / 244
页数:9
相关论文
共 50 条
  • [21] Comparison between surgery and definitive chemoradiotherapy for patients with resectable esophageal squamous cell carcinoma: a propensity score analysis
    Motoo Nomura
    Isao Oze
    Takeshi Kodaira
    Tetsuya Abe
    Azusa Komori
    Yukiya Narita
    Toshiki Masuishi
    Hiroya Taniguchi
    Shigenori Kadowaki
    Takashi Ura
    Masashi Andoh
    Hiroyuki Tachibana
    Norihisa Uemura
    Masahiro Tajika
    Yasumasa Niwa
    Manabu Muto
    Kei Muro
    International Journal of Clinical Oncology, 2016, 21 : 890 - 898
  • [22] Correspondence: Statin Use During Concurrent Chemoradiotherapy With Improved Survival Outcomes in Esophageal Squamous Cell Carcinoma: A Propensity Score- Matched Nationwide Cohort Study
    Lin, Ting-An
    Che, Ssu-Yu
    Chang, Renin
    Sun, Cheuk-Kwan
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (10)
  • [23] Treatment Outcomes and the Safety of Chemoradiotherapy With High-Dose CDDP for Elderly Patients With Head and Neck Squamous Cell Carcinoma: A Propensity Score Matching Study
    Omata, Jo
    Ueki, Yushi
    Takahashi, Takeshi
    Shodo, Ryusuke
    Yamazaki, Keisuke
    Saijo, Kohei
    Ota, Hisayuki
    Togashi, Takafumi
    Sato, Yuichiro
    Horii, Arata
    FRONTIERS IN SURGERY, 2021, 8
  • [24] Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis
    Wei Huang
    Leilei Wu
    Xuan Liu
    Hao Long
    Tiehua Rong
    Guowei Ma
    Journal of Cardiothoracic Surgery, 14
  • [25] Preoperative serum C-reactive protein levels and postoperative survival in patients with esophageal squamous cell carcinoma: a propensity score matching analysis
    Huang, Wei
    Wu, Leilei
    Liu, Xuan
    Long, Hao
    Rong, Tiehua
    Ma, Guowei
    JOURNAL OF CARDIOTHORACIC SURGERY, 2019, 14 (01)
  • [26] Comparison of neoadjuvant chemoradiotherapy versus chemoradiotherapy plus immunotherapy for esophageal squamous cell carcinoma in a real-world multicenter cohort: a propensity score matching study
    Shi, Shuming
    Zhou, Hao
    Li, Li
    Xu, Fuhao
    Liu, Ning
    Zhang, Dexian
    Xu, Xiaohui
    Sun, Yawen
    Yuan, Shuanghu
    SCIENTIFIC REPORTS, 2024, 14 (01):
  • [27] Concurrent Chemoradiotherapy in Elderly Patients with Locally Advanced Esophageal Carcinoma
    Jung, Bae Kwon
    Kang, Ki Mun
    Lee, Gyeong Won
    Kang, Jung Hoon
    Kim, Hoon Gu
    Lee, Won Seob
    Chai, Gyu Young
    RADIATION ONCOLOGY JOURNAL, 2009, 27 (02): : 84 - 90
  • [28] Concurrent chemoradiotherapy alone is feasible for esophageal squamous cell carcinoma patients not suitable for surgery
    Chen, Yongshun
    Wang, Jun
    RADIOTHERAPY AND ONCOLOGY, 2018, 129 (01) : 182 - 182
  • [29] Family history of cancer is a prognostic factor for better survival in operable esophageal squamous cell carcinoma: A propensity score matching analysis
    Zhang, Shuishen
    Chen, Junying
    Li, Bin
    Cai, Xiaoli
    Wang, Kexi
    Tan, Zihui
    Zheng, Yuzhen
    Liu, Qianwen
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [30] A new prognostic score for the survival of patients with esophageal squamous cell carcinoma
    Masaki Nakamura
    Makoto Iwahashi
    Mikihito Nakamori
    Toshiyasu Ojima
    Masahiro Katsuda
    Takeshi Iida
    Keiji Hayata
    Tomoya Kato
    Hiroki Yamaue
    Surgery Today, 2014, 44 : 875 - 883